Skip to research content
Public research library
Topic MFN

Most favored pricing and market check

Published findings, original references and room for an evidence-backed challenge.

What the rubric looks for

The plan automatically receives pricing at least as good as any comparable client, and can run an annual market check with a meet, credit or release remedy.

Why it matters

Multi-year contracts drift out of market. Without a market check the plan is locked into stale pricing.

MFN · Weight 3/100 · Introduced in rubric v1

Reference: Section 8

Only the selected record is loaded. Findings below are not a cross-contract tally or community activity.

Published evidence

Travis County · Envision Pharmaceutical Services, LLC

Published Commons finding

Not addressedFinding rubric version not recorded

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. All five models reached this verdict. Pricing is fixed in the summary tables on pages 10 and 11 with no most favored client promise and no annual market check, and there is no meet, credit or release remedy. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Inspect historical council readings (5 recorded for this criterion)

These are separately attributed readings of this record, not independent community contributions. Versions can differ; no new consensus has been calculated.

Claude Opus 5

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The packet contains no most favored pricing promise and no market check. Pricing is fixed in the summary tables on pages 10 and 11 with no mechanism to test it against what comparable clients receive during the term. There is no meet, credit or release remedy, and the executed agreement that could contain one is not in this backup.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Gemini 3.1 Pro

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. Most favored nation pricing and market check rights are not addressed in the provided summary documents.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

GPT 5.6 Sol

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The pricing discussion and tables on pages 10 and 11 contain no most-favored pricing promise and no annual market-check procedure. There is no meet, credit, or release remedy tied to market results. The executed agreement is not included, so any such right cannot be assessed.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Grok 4.6

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. Pages 8 through 11 and 16 through 18 contain no most favored customer, comparable client, or annual market check with a meet, credit, or release remedy. The 9.5% spend reduction guarantee on pages 2 and 10 is a savings promise, not an MFN. Market-check rights are not in this backup.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Kimi K3

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. No page grants most favored client pricing or an annual market check with a meet, credit or release remedy. The three year term on page 16 has no companion market check provision in this file. Such a clause would be contract language the backup does not contain.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Document manifest and citation limits

Quotations and rationales are reproduced from published findings, not newly verified here. Named exhibits, amendments and ambiguous references must be checked in the document itself.

Community participation

Have contrary evidence, a missing exhibit or a question about the interpretation? Use the existing community composer to prepare a labelled finding. Publishing a community post is separate from a Commons review and does not change the contract score.

This research topic is not a membership channel. Following topics and private agency workspaces are not enabled here.

PBM Commons · by BetterBuy RxEvidence is public. Interpretation is open to review.

Commons navigation

Find a public record